What is he best known for?
The fields of study he is best known for:
- Cancer
- Internal medicine
- Radiology
Ken Herrmann spends much of his time researching Nuclear medicine, Prostate cancer, Radiology, Positron emission tomography and Internal medicine.
His Nuclear medicine study combines topics in areas such as Biopsy, Somatostatin receptor and CXCR4.
His research on Prostate cancer often connects related topics like Radiation treatment planning.
His work in the fields of Radiology, such as PET-CT and Gold standard, intersects with other areas such as In patient.
His Positron emission tomography research integrates issues from Cancer, Predictive value of tests, Magnetic resonance imaging and Non-Hodgkin's lymphoma.
His Internal medicine research is multidisciplinary, relying on both Gastroenterology, Oncology and Fluorodeoxyglucose.
His most cited work include:
- PET to assess early metabolic response and to guide treatment of adenocarcinoma of the oesophagogastric junction: the MUNICON phase II trial. (622 citations)
- Metabolic imaging predicts response, survival, and recurrence in adenocarcinomas of the esophagogastric junction. (374 citations)
- The detection rate of [11C]choline-PET/CT depends on the serum PSA-value in patients with biochemical recurrence of prostate cancer. (310 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of study are Nuclear medicine, Radiology, Positron emission tomography, Internal medicine and Prostate cancer.
His Nuclear medicine research is multidisciplinary, incorporating elements of Lesion, Prostatectomy and Histopathology.
His work deals with themes such as Breast cancer and Lymph node, which intersect with Radiology.
Ken Herrmann focuses mostly in the field of Positron emission tomography, narrowing it down to matters related to Pathology and, in some cases, CXCR4.
Ken Herrmann interconnects Gastroenterology and Oncology in the investigation of issues within Internal medicine.
His studies deal with areas such as Cancer research, Radiation therapy and Radioligand as well as Prostate cancer.
He most often published in these fields:
- Nuclear medicine (30.77%)
- Radiology (25.25%)
- Positron emission tomography (24.06%)
What were the highlights of his more recent work (between 2019-2021)?
- Prostate cancer (20.91%)
- Internal medicine (22.09%)
- Nuclear medicine (30.77%)
In recent papers he was focusing on the following fields of study:
Prostate cancer, Internal medicine, Nuclear medicine, Oncology and Radiology are his primary areas of study.
His Prostate cancer study combines topics from a wide range of disciplines, such as PET-CT, Radiation therapy, Radionuclide therapy and Radioligand.
His work on Clinical trial, Castration resistant, Retrospective cohort study and Cancer as part of general Internal medicine research is often related to In patient, thus linking different fields of science.
His study involves Positron emission tomography and Standardized uptake value, a branch of Nuclear medicine.
His Positron emission tomography research is multidisciplinary, incorporating perspectives in Breast cancer and Magnetic resonance imaging.
His Radiology study incorporates themes from Prospective cohort study and Lymph node.
Between 2019 and 2021, his most popular works were:
- COVID-19 pandemic: guidance for nuclear medicine departments. (44 citations)
- Nuclear Medicine Operations in the Times of COVID-19: Strategies, Precautions, and Experiences. (41 citations)
- EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer—An International Collaborative Multistakeholder Effort† (36 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Cancer
- Radiology
His scientific interests lie mostly in Nuclear medicine, Prostate cancer, Internal medicine, In patient and Positron emission tomography.
His work on Standardized uptake value as part of general Nuclear medicine research is frequently linked to International survey, bridging the gap between disciplines.
His Prostate cancer research incorporates elements of Biomarker, PET-CT, Interquartile range and Orchiectomy.
His Internal medicine research includes themes of Gastroenterology, Oncology and Coping.
His Positron emission tomography research is under the purview of Radiology.
His biological study spans a wide range of topics, including Neuroimaging, Intrahepatic Cholangiocarcinoma and Limbic system.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
